Latest Insider Transactions at Laboratory Corp Of America Holdings (LH)
This section provides a real-time view of insider transactions for Laboratory Corp Of America Holdings (LH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LABORATORY CORP OF AMERICA HOLDINGS to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LABORATORY CORP OF AMERICA HOLDINGS's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 18
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,413
-41.49%
|
$347,598
$246.1 P/Share
|
Feb 18
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+29.32%
|
$230,319
$163.63 P/Share
|
Feb 11
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41
-1.72%
|
$10,045
$245.14 P/Share
|
Feb 11
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
123
+4.9%
|
-
|
Feb 11
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
55
-1.14%
|
$13,475
$245.14 P/Share
|
Feb 11
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+4.0%
|
-
|
Feb 11
2025
|
Adam H Schechter President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,226
-1.37%
|
$300,370
$245.14 P/Share
|
Feb 11
2025
|
Adam H Schechter President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,963
+3.21%
|
-
|
Feb 11
2025
|
Adam H Schechter President & CEO |
SELL
Open market or private sale
|
Direct |
6,121
-6.61%
|
$1,493,524
$244.62 P/Share
|
Feb 11
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
86
-0.51%
|
$21,070
$245.14 P/Share
|
Feb 11
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
323
+1.89%
|
-
|
Feb 11
2025
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
213
-0.64%
|
$52,185
$245.14 P/Share
|
Feb 11
2025
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
807
+2.36%
|
-
|
Feb 11
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-2.05%
|
$32,830
$245.14 P/Share
|
Feb 11
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
473
+6.75%
|
-
|
Feb 11
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
86
-2.41%
|
$21,070
$245.14 P/Share
|
Feb 11
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
323
+8.3%
|
-
|
Feb 11
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-0.46%
|
$33,320
$245.14 P/Share
|
Feb 11
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
473
+1.58%
|
-
|
Feb 11
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
42
-1.39%
|
$10,290
$245.14 P/Share
|
Feb 11
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
134
+4.25%
|
-
|
Feb 07
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-0.57%
|
$23,124
$246.27 P/Share
|
Feb 07
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
354
+2.1%
|
-
|
Feb 07
2025
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
234
-0.71%
|
$57,564
$246.27 P/Share
|
Feb 07
2025
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
885
+2.62%
|
-
|
Feb 07
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
182
-0.31%
|
$44,772
$246.27 P/Share
|
Feb 07
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
629
+1.07%
|
-
|
Feb 07
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
193
-1.58%
|
$47,478
$246.27 P/Share
|
Feb 07
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
681
+5.22%
|
-
|
Feb 07
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
68
-1.45%
|
$16,728
$246.27 P/Share
|
Feb 07
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
224
+4.56%
|
-
|
Feb 07
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
51
-1.74%
|
$12,546
$246.27 P/Share
|
Feb 07
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
149
+4.83%
|
-
|
Feb 07
2025
|
Megan D. Bailey EVP, Pres, Central Labs & Intl |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-6.98%
|
$26,322
$246.27 P/Share
|
Feb 07
2025
|
Megan D. Bailey EVP, Pres, Central Labs & Intl |
BUY
Exercise of conversion of derivative security
|
Direct |
291
+15.36%
|
-
|
Feb 07
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-2.81%
|
$23,124
$246.27 P/Share
|
Feb 07
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
354
+9.58%
|
-
|
Feb 07
2025
|
Adam H Schechter President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,345
-1.43%
|
$330,870
$246.27 P/Share
|
Feb 07
2025
|
Adam H Schechter President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,250
+3.35%
|
-
|
Feb 07
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-1.99%
|
$11,316
$246.27 P/Share
|
Feb 07
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
134
+5.49%
|
-
|
Feb 07
2025
|
Anita Z Graham EVP, CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
119
-13.69%
|
$29,274
$246.27 P/Share
|
Feb 07
2025
|
Anita Z Graham EVP, CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
369
+29.81%
|
-
|
Feb 06
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-0.58%
|
$23,218
$247.74 P/Share
|
Feb 06
2025
|
Lance Berberian EVP, Special Advisor, Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
356
+2.14%
|
-
|
Feb 06
2025
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
255
-0.79%
|
$62,985
$247.74 P/Share
|
Feb 06
2025
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
966
+2.91%
|
-
|
Feb 06
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-0.74%
|
$52,364
$247.74 P/Share
|
Feb 06
2025
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
670
+2.28%
|
-
|
Feb 06
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
210
-3.63%
|
$51,870
$247.74 P/Share
|